Peter van der Meer


Professor Peter van der Meer received both his MD and PhD cum laude from the University of Groningen in the Netherlands. He is trained as a cardiologist with a focus on heart failure and cardiac devices. He did a postdoctoral fellowship at Harvard Medical School with prof. Ken Chien to further train his skills in cardiac stem cell biology.

The group of Prof. Van der Meer consists of PhD students, technicians and post-docs with various backgrounds (biologists, medical doctors, and biomedical-engineers) working on translational research topics to bridge the gap between bench and bedside. His group focuses on understanding the susceptibility to develop heart failure and exploring novel treatment targets and therapies. He is a member of several steering committees of large morbidity and mortality trials investigating the impact of new and old drugs in patients with heart failure, including digoxin and iron.

We are always happy to discuss positions and vacancies with highly motivated and ambitious (bio)medical students with a strong affiliation with topics related to heart failure, in vitro disease modeling, clinical studies, statistics, and/or epidemiology. We often host visiting scientist from abroad.


Current activities

Prof. Van der Meer is a member of the ESC council of cardio-oncology, member of the working group on translational cardiology and peripartum cardiomyopathy of the ESC and associate editor of the European Journal of Heart Failure. He is currently medical director of the coronary care unit of the University Medical Center Groningen.

“A better understanding of why patients develop heart failure will eventually lead to a targeted approach and precision medicine.”

Mijn projecten


Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the Netherlands: DECISION

Transthyretin amyloidosis cardiomyopathy

Selenium en hartfalen

Translationeel onderzoek gefocust op de synergie tussen leefstijl interventies en het behandelen van hartfalen.

Mijn publicaties

Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.

Van der Pol A, Gil A, Silljé HHW, Tromp J, Ovchinnikova ES, Vreeswijk-Baudoin I, Hoes M, Domian IJ, van de Sluis B, van Deursen JM, Voors AA, van Veldhuisen DJ, van Gilst WH, Berezikov E, van der Harst P, de Boer RA, Bischoff R, van der Meer P. Science Transl Med. 2017.

view on publisher site

Selenium and outcome in heart failure

Bomer N, Grote Beverborg N, Hoes MF, Streng KW, Vermeer M, Dokter MM, IJmker J, Anker SD, JF Cleland, Hillege HL, Lang CC, Ng LL, Samani NJ, Tromp J, van Veldhuisen DJ, Touw DJ, Voors AA, van der Meer P. Eur J Heart Fail. 2019

view on publisher site

Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function.

Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, Rodenburg RJ, Veldhuisen DJ van, Boer RA de, Meer P van der. Eur J Heart Fail. 2018

view on publisher site